RxDoctor Payments Data

Julie Farrington, MD

Psychiatry · Austin, TXNPI 1427114545

Payments from drug & device makers

$204,703in general payments, 2019–2025

Across 149 payments — averaging $1373.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Livanova USA, Inc.$164K
  • Janssen Research & Development, LLC$29K
  • Boehringer Ingelheim$9K
  • Supernus Pharmaceuticals, Inc.$2K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$1K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$204,703 in reported general payments places this provider in the 95th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Medicare billing

Part B allowed, 2024
$5,930
Medicare patients
15
Services billed
50

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Duloxetine Hcl16$767
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine16$637
Mirtazapine21$324
Clonazepam13$78

Paid to pharmacies, not to this prescriber.

Other psychiatry in Austin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →